I 
112TH CONGRESS 
1ST SESSION H. R. 3554 
To prohibit the open-air cultivation of genetically engineered pharmaceutical 
and industrial crops, to prohibit the use of common human food or 
animal feed as the host plant for a genetically engineered pharmaceutical 
or industrial chemical, to establish a tracking system to regulate the 
growing, handling, transportation, and disposal of pharmaceutical and 
industrial crops and their byproducts to prevent human, animal, and 
general environmental exposure to genetically engineered pharmaceutical 
and industrial crops and their byproducts, to amend the Federal Food, 
Drug, and Cosmetic Act with respect to the safety of genetically engi-
neered foods, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
DECEMBER 2, 2011 
Mr. KUCINICH (for himself, Mr. GRIJALVA, and Mr. STARK) introduced the 
following bill; which was referred to the Committee on Agriculture, and 
in addition to the Committee on Energy and Commerce, for a period to 
be subsequently determined by the Speaker, in each case for consider-
ation of such provisions as fall within the jurisdiction of the committee 
concerned 
A BILL 
To prohibit the open-air cultivation of genetically engineered 
pharmaceutical and industrial crops, to prohibit the use 
of common human food or animal feed as the host plant 
for a genetically engineered pharmaceutical or industrial 
chemical, to establish a tracking system to regulate the 
growing, handling, transportation, and disposal of phar-
maceutical and industrial crops and their byproducts to 
prevent human, animal, and general environmental expo-
VerDate Mar 15 2010 
23:25 Dec 05, 2011
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6652
E:\BILLS\H3554.IH
H3554
mstockstill on DSK4VPTVN1PROD with BILLS
sure to genetically engineered pharmaceutical and indus-
trial crops and their byproducts, to amend the Federal 
Food, Drug, and Cosmetic Act with respect to the safety 
of genetically engineered foods, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 
(a) SHORT TITLE.—This Act may be cited as the 
‘‘Genetically Engineered Safety Act’’. 
(b) TABLE OF CONTENTS.—The table of contents for 
this Act is as follows: 
Sec. 1. Short title; table of contents. 
TITLE I—GENETICALLY ENGINEERED PHARMACEUTICAL AND 
INDUSTRIAL CROP SAFETY 
Sec. 101. Short title. 
Sec. 102. Findings. 
Sec. 103. Definitions. 
Sec. 104. Regulation of production of pharmaceutical crops and industrial 
crops. 
Sec. 105. Civil penalties for violation. 
Sec. 106. Report to Congress on alternative methods to produce pharmaceutical 
and industrial crops. 
TITLE II—GENETICALLY ENGINEERED FOOD SAFETY 
Sec. 201. Short title. 
Sec. 202. Findings. 
Sec. 203. Federal determination of safety of genetically engineered food; regula-
tion as food additive. 
Sec. 204. User fees regarding determination of safety of genetic food additives. 
Sec. 205. Embargo authority. 
Sec. 206. Rulemaking; effective date; previously unregulated marketed addi-
tives. 
VerDate Mar 15 2010 
23:25 Dec 05, 2011
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6211
E:\BILLS\H3554.IH
H3554
mstockstill on DSK4VPTVN1PROD with BILLS
TITLE 
I—GENETICALLY 
ENGI-
NEERED 
PHARMACEUTICAL 
AND INDUSTRIAL CROP SAFE-
TY 
SEC. 101. SHORT TITLE. 
This title may be cited as the ‘‘Genetically Engi-
neered Pharmaceutical and Industrial Crop Safety Act of 
2011’’. 
SEC. 102. FINDINGS. 
Congress finds the following: 
(1) A pharmaceutical crop or industrial crop is 
a plant that has been genetically engineered to 
produce a medical or industrial product, including a 
human or veterinary drug, biologic, industrial, or re-
search chemical, or enzyme. 
(2) The Department of Agriculture has issued 
more than 270 permits for more than 300 outdoor 
field trials of plants genetically engineered to 
produce experimental pharmaceuticals, industrial en-
zymes and novel proteins. More than 80 percent of 
the field trial permits involved feed crops, including 
corn, soybeans, rice, safflower, barley, alfalfa, mus-
tard greens, peas, sugarcane, tomatoes, and wheat. 
(3) Many of the novel substances produced in 
pharmaceutical crops and industrial crops exhibit 
VerDate Mar 15 2010 
23:25 Dec 05, 2011
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H3554.IH
H3554
mstockstill on DSK4VPTVN1PROD with BILLS